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Abstract We have derived the full-length sequences of the
human and rat forms of the multiple inositol polyphosphate
phosphatase (MIPP); their structural and functional comparison
with a chick histidine acid phosphatase (HiPER1) has revealed
new information: (1) MIPP is approximately 50% identical to
HiPER1, but the ER-targeting domains are divergent; (2) MIPP
appears to share the catalytic requirement of histidine acid
phosphatases, namely, a C-terminal His residue remote from the
RHGxRxP catalytic motif ; (3) rat MIPP mRNA is up-
regulated during chondrocyte hypertrophy. The latter observa-
tion provides a context for proposing that MIPP may aid bone
mineralization and salvage the inositol moiety prior to apoptosis.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
By determining the structural and functional relationships
that exist between proteins from di¡erent organisms, we can
gain insight into their evolutionary origins and physiological
roles. This is the approach taken in the current study of the
multiple inositol polyphosphate phosphatase (MIPP), as part
of our overall goal of determining the signi¢cance to the cell
of this enzyme’s ability to dephosphorylate a number of in-
ositol phosphates, including Ins(1,3,4,5)P4, InsP5 and InsP6
[1,2].
We have previously obtained a partial cDNA clone that
encodes a truncated rat hepatic MIPP (rMIPP) [1]. This pro-
tein possesses the RHGxRxP catalytic motif that de¢nes
members of the histidine acid phosphatase family [3^5]. Out-
side this motif, there is considerable variation in the sequence
of individual histidine acid phosphatases, re£ecting the fact
that these enzymes serve a multitude of functions [6]. The
member of this family that comes closest in sequence similar-
ity to rMIPP (approx. 50%, see below) is a chick chondrocyte
protein, HiPER1449 (histidine acid phosphatase of the endo-
plasmic reticulum) [7,8]. rMIPP is also an ER-based protein
[9]. Interestingly, the levels of avian HiPER1449 mRNA are
up-regulated in bone growth plates during chondrocyte hyper-
trophy [7,8]. The possibility that MIPP is functionally related
to HiPER1449 could re£ect the importance to endochondral
ossi¢cation of an accelerated metabolism of inositol phos-
phates. However, such speculation is premature; alternative
splicing generates several variants of HiPER1, each of which
may have speci¢c functions [7]. It is not known if any of these
HiPER1 proteins can hydrolyze inositol phosphates [8]. Thus,
it was a goal of the current study to improve our understand-
ing of the structural and functional relationship between the
MIPP and HiPER1 families.
The procurement of additional structural information was
facilitated by our sequencing a full-length cDNA of a human
form of MIPP (hMIPP), and by extending the cDNA for
rMIPP to include the predicted initiator codon. One new de-
velopment to arise from this molecular study was the identi-
¢cation and comparison of the N-terminal ER-targeting do-
mains of the MIPP and HiPER1 proteins. This is signi¢cant
because ER-targeting regions are not all functionally equiva-
lent, so there is considerable interest in understanding how
their amino acid sequence determines which mechanisms of
protein entry into the ER are utilized [10,11]. Another facet to
our structural analysis relates to an emerging opinion that
groups of histidine acid phosphatases may have similar terti-
ary structures despite their primary sequences being quite di-
vergent [4,12]. To take one example, this family has the gen-
eral catalytic requirement that the three-dimensional structure
must permit the N-terminal RHGxRxP catalytic motif to be
juxtaposed to a remote, C-terminal HD proton donor pair
[3^5]. However, neither MIPP [1] nor HiPER1 [8] possesses
an HD dipeptide; we therefore investigated how this unusual
feature might be relevant to the relationship that MIPP and
HiPER1 have to other histidine acid phosphatases.
In parallel with these structural goals, the key functional
objective was to determine the pattern of expression of
MIPP mRNA in developing rat chondrocytes, and to com-
pare these data with earlier studies [8] of HiPER1 mRNA in
chick chondrocytes. The results of these experiments provide
direct evidence to indicate that changes in inositol phosphate
metabolism may be an important aspect of bone development.
2. Materials and methods
2.1. Sequencing
EST cDNAs were obtained from ATCC. DNA was prepared by
Qiagen Maxiprep. Both strands of each clone were completely se-
quenced, in-house and by Sequetech Corp. (Mountain View, CA),
using a £uorescent dye-based chemistry.
2.2. 5P RACE of rat MIPP cDNA
5P RACE reactions were carried out using Marathon-Ready rat
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liver and rat kidney cDNAs (Clontech). Initial PCR reactions were
performed using a number of antisense primers to rMIPP, and the
adaptor primer AP1 (Clontech). Aliquots of these primary PCR re-
actions were then used in PCR reactions using nested rMIPP antisense
primers and AP2 (Clontech). Individual PCR products were gel-puri-
¢ed, cloned into the TA cloning vector pCR2.1 (Invitrogen), and
sequenced. RACE products of varying lengths were obtained, the
longest of which encoded the rMIPP predicted sequence from Arg-5
onward (see Section 3). This RACE sequence was con¢rmed and
extended to the putative initiator Met by sequence analysis of a rat
genomic clone which encodes the rMIPP cDNA (Ca¡rey and Shears,
unpublished data).
2.3. Expression of recombinant proteins in Escherichia coli
We prepared nucleotide constructs to encode recombinant forms of
hMIPP and hMLP (human MIPP-like protein); in both cases the
sequence MRGSH6GS replaced the N-terminal 30 residues of the
predicted ER-targeting domain of the native proteins. The appropri-
ate cDNA coding regions were ampli¢ed by PCR, using a 5P primer
that contained a BamHI site and a 3P primer that contained a SalI
site. PCR products of the expected size were digested with BamHI and
SalI, and cloned individually into these sites in the vector pQE30
(Qiagen). The His370Ala hMIPP mutant was generated by ‘recombi-
nant PCR’: sense and antisense mutagenic primers were used in
separate primary PCR reactions with, respectively, 3P (TCATAGTT-
CATCAGATGTACTGTTAGC) and 5P (GATATGGAGTTTGGA-
CCTCC) external primers. Aliquots of the two PCR products gener-
ated were mixed, and ampli¢ed in a second round of PCR using the 5P
and 3P external primers only. A single 840 bp PCR product was
obtained, digested with EcoRV and NsiI, and the desired 177 bp
EcoRV-NsiI fragment was gel-puri¢ed and used to replace the cognate
fragment in recombinant hMIPP. The nucleotide sequence of each
construct was veri¢ed by sequencing (see above), transformed into
E. coli strain M15, and protein production was induced as follows:
overnight 50 ml cultures were diluted ¢ve-fold into LB containing 100
Wg/ml ampicillin and 25 Wg/ml kanamycin, and grown at 37‡C to an
OD600 of 0.6^0.8. Cultures were induced with 0.1 mM IPTG for 2 h at
23‡C. The cells were pelleted by centrifugation, and recombinant His-
tagged proteins were puri¢ed as described below.
2.4. A⁄nity puri¢cation of recombinant hMIPP and hMLP
Puri¢cation was performed at 0^4‡C. Cells were lysed for 15^30
min in 10 ml bu¡er A (50 mM Tris-HCl, pH 8.5; 300 mM KCl; 20
mM L-mercaptoethanol; 0.25 mM AEBSF; 10 WM E-64; 10 Wg/ml
leupeptin; 1 Wg/ml pepstatin A; 10 mg/ml lysozyme). Next, 4 mM
CHAPS was added, and samples were sonicated. Lysates were centri-
fuged at 17 000Ug for 15 min, and the resulting supernatants (10 ml)
were incubated with 0.2 ml Ni-NTA Agarose (50% slurry; Qiagen)
with gentle rocking for 15^30 min. The beads were washed succes-
sively with 1 ml of each of the following bu¡ers: B (20 mM Tris-HCl,
pH 8.5; 300 mM KCl; 10% glycerol; 20 mM L-mercaptoethanol), C
(as for B, but 2 M NaCl replaced the 300 mM KCl), D (bu¡er B plus
30% glycerol, 1% Triton X-100). Beads were then re-equilibrated in B.
Proteins were eluted with 0.4 ml of 20 mM Tris-HCl, pH 8.5; 100 mM
KCl; 10% glycerol; 200 mM imidazole, and analyzed by SDS-PAGE
using 12% polyacrylamide Tris-glycine gels (Novex). Recombinant
hMIPP was detected using an anti-RSG(H)4 mouse monoclonal anti-
body (Qiagen). Recombinant hMLP was detected using an antibody
raised against the unique hMLP C-terminus (CFLSWATSKTRNP).
The appropriate HRG-conjugated, anti-IgG secondary antibodies
were supplied by Amersham. Pierce Supersignal reagent was used
for chemiluminescent detection. MIPP activity was assayed as previ-
ously described [1].
2.5. In situ hybridization and Northern blotting
To generate in situ hybridization riboprobes, two rMIPP cDNA
subclones were constructed in pBluescript II SK3. One construct con-
tained the 730 bp SpeI-ApaI fragment (nt 1302^2031 from the rMIPP
3P-non-translates sequence (NTS), see [1]). The second construct con-
tained a 232 bp BamHI-XhoI cDNA fragment (nt 698^929 from
rMIPP, see [1]) which was generated by PCR using the following
PCR cloning primers: 5P-TAATCGCGGATCCACTTAATTCAGG-
TAGCCTTTTTC-3P (forward), 5P-TAAGATACTCGAGCTTTGC-
TTCTGCTCAACTGC-3P (reverse). Digoxigenin-labeled sense and
antisense RNA probes were generated with T3 and T7 RNA polymer-
ases, respectively, using an RNA synthesis kit (Nippon Gene, Toya-
ma, Japan). The in situ hybridization was performed according to the
method described previously [13] using the tibia from 6 day old rats.
Northern blots were performed using a 433 bp DIG-labeled DNA
probe encompassing nt 1619^2051 of the hMIPP 3P-NTS. Blots were
probed overnight at 50‡C in DIG EasyHyb solution and washed two
times in 0.1USSC/0.1% SDS for 15 min each at 50‡C. The hMIPP
mRNA was detected by chemiluminescence using an alkaline phos-
phatase-conjugated anti-DIG antibody and CDP-STAR (Boehringer
Mannheim), according to the manufacturer’s protocol.
3. Results and discussion
3.1. Molecular cloning and expression of hMIPP; structural
comparison with rMIPP and HiPER1
To improve our understanding of the structure-function
relationship within the MIPP family, we have identi¢ed a
full-length cDNA of hMIPP by sequencing an EST cDNA
(GenBank accession number AA312011) that the BLAST al-
gorithm indicated was similar to the nucleotide sequence of
rMIPP [1]. The hMIPP cDNA, which originates from Jurkat
T-cells, has an open reading frame encoding a predicted pro-
tein of 487 amino acids (Fig. 1). The 2412 bp nucleotide
sequence contains an initiator codon within an adequate Ko-
zak consensus [14], and an in-frame TGA stop codon. The 3P-
NTS contains two polyadenylation signals and a polyA tail.
The hMIPP sequence from nt 557 to 2412 was also found in
an independent EST cDNA (GenBank accession number
AA315402) isolated from human colon. A 2.5 kb hMIPP
mRNA was seen in all tested tissues, except for peripheral
blood leukocytes; the most prominent expression was in kid-
ney, liver and placenta (Fig. 2).
Recombinant, His-tagged hMIPP was expressed in E. coli
without its ER-targeting domain, since this is expected to be
cleaved in vivo, once the protein has entered the ER [15]. The
theoretical size of the expressed protein is 53.4 kDa. Western
blotting identi¢ed a protein of approx. 51 kDa (Fig. 3, lane 2).
This protein expressed the enzyme activity that characterizes
the MIPP protein family, namely, a Mg2-independent hy-
drolysis of the 3-phosphate of Ins(1,3,4,5)P4 (Km of 1.6 þ 0.7
WM, n = 5). HPLC was used to identify Ins(1,4,5)P3 as the
reaction product (data not shown). The rate of Ins(1,3,4,5)P4
hydrolysis by the recombinant enzyme was typically 80-fold
greater than the activity obtained from parallel preparations
made from vector-transformed control cultures (Fig. 4).
In order to complete our comparison of hMIPP with
rMIPP, we have added additional 5P-nucleotide sequence
(see Section 2) to our previously truncated rMIPP cDNA,
which now encodes a predicted full-length rMIPP protein
(Fig. 1). The amino acid sequences of hMIPP and rMIPP
are 84% identical ; these proteins are less closely related to
HiPER1449 from chick chondrocytes (52^54% identical)
(Fig. 1).
The N-termini of both MIPP proteins contain the three
distinct domains (‘c’, ‘h’ and ‘n’, see Fig. 1) that typify an
ER-targeting sequence [16]. Hydropathy analysis (see legend
to Fig. 1) indicated that residues 14^24 in hMIPP, and resi-
dues 11^24 in rMIPP, each comprise the necessary hydropho-
bic core (the h region). The preceding n region has the re-
quired net positive charge (from two Arg in hMIPP, and two
Arg and a His in rMIPP, Fig. 1). Von Heijne’s rules [17] were
satis¢ed by the six residues of the candidate c region (a typical
length for this region [17]), which serves as a recognition site
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for the signal peptidases (Fig. 1). This new information pro-
vides us with the ¢rst opportunity to determine that the MIPP
ER-targeting sequences are not conserved in HiPER1 (Fig. 1).
Additionally, the putative n regions of the MIPP proteins (13
residues in hMIPP, 10 in rMIPP) are longer than that of
HiPER1 (¢ve residues). The latter observation is relevant to
evidence that n regions of ¢ve residues or less occur in pro-
teins for which delivery into the ER depends upon the trans-
locating chain-associating membrane protein (TRAM) [11]. In
contrast, TRAM-independent translocation may be a prop-
erty of proteins where the n region is larger than nine residues
[11]. Thus, MIPP and HiPER1 may be targeted into the ER
by di¡erent mechanisms.
3.2. A catalytic requirement for the C-terminus of hMIPP
Sequencing of a human CFPAC-1 cell EST cDNA (Gen-
Bank accession number AA161161) with a 2165 bp insert
revealed a putative coding region identical to that of hMIPP
cDNA, except for a 232 nt deletion which also introduces a
single base shift in the reading frame. Thus, the CFPAC-1
cDNA encodes a 312 residue hMLP; the N-terminal 278 res-
idues are identical to those in hMIPP (Fig. 1), but the 34
residue carboxy terminus of hMLP (GLSQFLLQSSSSLVM-
QRLFFHCFLSWATSKTRNP) is unique. We failed to detect
any hMLP upon Western analysis of extracts of CFPAC-1
cells (data not shown). Moreover, there was no evidence for
an appropriately sized hMLP mRNA in human multiple tis-
sue Northern blots (Fig. 2). A His-tagged construct of re-
combinant hMLP was expressed in E. coli. (Fig. 3, lane 4),
but this did not exhibit any 3-phosphatase activity (data not
shown). The GenBank accession number for the hMLP clone
is AF084944.
It is possible that the hMLP cDNA arises as a consequence
of a cloning artifact. Nevertheless, the fact that recombinant
hMLP did not express 3-phosphatase activity suggests a cata-
lytic requirement for the carboxy terminus of hMIPP, that is
missing from hMLP. Indeed, the carboxy portion of histidine
acid phosphatases typically contains an HD pair that is uti-
lized as a proton donor during catalysis [3^5]. MIPP and
HiPER1 are atypical, since they lack any HD dipeptides
(Fig. 1). However, the His residue within the HD motif of
other acid phosphatases has been aligned with His-332 of
HiPER1449 [8]. Multiple sequence analysis suggested that
this same histidine residue is conserved in MIPP (His-370 in
FEBS 21381 4-1-99
Fig. 1. Comparison of the sequences of the MIPP and HiPER1 families. The amino acid sequence of hMIPP was deduced from the corre-
sponding nucleotide sequence (GenBank accession number is AF084943). The rMIPP sequence is as previously published [1], plus the com-
pleted N-terminus deduced from the extra 5P-nucleotide sequence we have now obtained (see Section 2). The HiPER1449 sequence is as pub-
lished previously [8]. Residues that are identical to those of hMIPP are highlighted in bold type. The RHGxRxP catalytic motif is underlined,
and an asterisk marks a conserved His residue with a proposed catalytic role (see text). The arrow marks the HiPER1318 C-terminus [8]. The
predicted ER targeting domains are boxed, and divided into the following subdomains: the c region (gray), h region (white) and n region
(gray). These were identi¢ed using von Heijne’s rules [17], and hydropathy analysis [24]. Mean hydropathy values (window = 8) were as follows:
hMIPP, n =30.6, h =31.9, c =30.9; rMIPP, n = +0.24, h =32.2, c =30.65; HiPER1, n =30.5, h =32.2, c =31.1.
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hMIPP, Fig. 1). Therefore, a His370Ala mutant of hMIPP
was generated by site-directed mutagenesis; this protein ex-
pressed 6 5% of the activity of the wild-type enzyme (Fig. 4).
The catalytic requirement for His-370, albeit in a novel con-
text, is further evidence of MIPP sharing mechanistic and
structural similarities with other histidine acid phosphatases.
The absence of an equivalent His residue in hMLP may help
account for why it is catalytically inactive. Our data also
suggest that HiPER1318, which also lacks this conserved His
residue (Fig. 1), will not hydrolyze inositol phosphates.
3.3. The pattern of expression of MIPP in rat chondrocytes
The expression of HiPER1449 mRNA is up-regulated during
chick chondrocyte hypertrophy [7,8]. To determine if rMIPP
is functionally similar to HiPER1, we used in situ hybridiza-
tion to investigate the expression pattern of rMIPP in rat
chondrocytes. Sense and antisense probes against rMIPP
RNA were applied across a longitudinal section of the growth
plate of 6 day old rat tibia (Fig. 5). It is possible to distinguish
the three zones that contain the resting (R), proliferating (P)
and hypertrophic (H) chondrocytes. The zone of hypertrophy
contains the most intense signal from the antisense probes
(Fig. 5c,d), and this signal is not evident when the sense
probes were used (Fig. 5a,b).
This demonstration that rMIPP expression is up-regulated
during rat chondrocyte hypertrophy represents the ¢rst direct
experimental evidence that rMIPP has some functional simi-
larity to HiPER1449. This observation provides a useful con-
text for considering the physiological advantage of rMIPP’s
substrates (Ins(1,3,4,5)P4, InsP5 and InsP6 [2]) being more
actively dephosphorylated during chondrocyte hypertrophy.
At this time, vesicles that will eventually mineralize the extra-
cellular matrix bud-o¡ from the chondrocyte plasma mem-
brane [18]. InsP6, which binds to cellular membranes [19]
and is present in cell cytosol [20], has the potential to become
trapped inside the matrix vesicles. The ability of InsP6 to
inhibit calcium phosphate crystal growth [21] could, therefore,
impede the mineralizing function of these vesicles. This situa-
tion may be avoided, prior to matrix vesicle formation, by
increased InsP6 hydrolysis as a result of up-regulation of
MIPP. Another aspect of the hypertrophic phenotype is that
it can commit chondrocytes to enter an apoptotic program
[22]. Increased MIPP activity may also serve to salvage for
other cells the important inositol moiety from the higher ino-
sitol phosphates that the apoptotic chondrocytes no longer
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Fig. 4. Catalytic activity of wild type hMIPP and a His370Ala mu-
tant. Recombinant wild-type hMIPP (n = 3), a His370Ala mutant
(n = 5), and samples of QE vector controls (n = 3) were assayed for
Ins(1,3,4,5)P4 3-phosphatase activity (panel B). The units of activity
(with S.E.M.s) are per Wl of stock enzyme, adjusted for any di¡eren-
ces in MIPP concentration, as determined by scanning densitometry
of silver-stained gels (panel A).
Fig. 3. Expression of recombinant hMIPP and hMLP in E. coli.
Samples of a⁄nity-puri¢ed, recombinant hMIPP (lane 2) and
hMLP (lane 4) were analyzed by SDS-PAGE and Western blotting
as described in Section 2. Lanes 1 and 3 represents an extract of af-
¢nity-puri¢ed proteins from cells transformed with vector alone.
Fig. 2. Expression of hMIPP in human tissues. A Clontech human
multiple tissue Northern blot was probed sequentially with digoxi-
gen-labeled MIPP-speci¢c and L-actin probes (see Section 2).
PBL = peripheral blood leukocytes.
J.J. Ca¡rey et al./FEBS Letters 442 (1999) 99^104102
require. This idea ¢ts the general concept that the body has
developed a number of means to conserve inositol [23].
The prediction that an increased rate of inositol phosphate
turnover is important to endochondral ossi¢cation would
have been premature without the new information generated
by this study concerning the structural and functional rela-
tionships between MIPP and HiPER1. Additionally, the clon-
ing of hMIPP may eventually be of clinical interest; increased
knowledge of the genetic control of mineralizing chondrocytes
is relevant to our understanding of normal bone growth, as
well as pathological situations such as fracture healing and
osteoarthritis [7].
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